138 filings
EFFECT
ALLO
Allogene Therapeutics Inc
26 Apr 24
Notice of effectiveness
12:15am
ARS
2023 FY
ALLO
Allogene Therapeutics Inc
23 Apr 24
Annual report to shareholders
4:33pm
DEFA14A
ALLO
Allogene Therapeutics Inc
23 Apr 24
Additional proxy soliciting materials
4:32pm
DEF 14A
ALLO
Allogene Therapeutics Inc
Definitive proxy
23 Apr 24
4:31pm
S-8
ALLO
Allogene Therapeutics Inc
14 Mar 24
Registration of securities for employees
5:28pm
S-3
ogueysasbon56uxnq
14 Mar 24
Shelf registration
5:21pm
POSASR
anu t6qwu72
14 Mar 24
Automatic shelf registration (post-effective amendment)
4:51pm
8-K
8vblp6 qb7
14 Mar 24
Allogene Therapeutics Reports Fourth Quarter and Full Year 2023
4:10pm
8-K
lg61vszt77a8f2ht4rc
16 Feb 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8:30am
8-K
ae1deu0q c4zwv
31 Jan 24
Entry into a Material Definitive Agreement
12:00am
8-K
8nhtii8u
5 Jan 24
Entry into a Material Definitive Agreement
8:00am
8-K
y96xxg3
19 Dec 23
Other Events
3:46pm
424B5
ax259 3xh8
2 Nov 23
Prospectus supplement for primary offering
4:41pm
8-K
o8zemhoaxvc 6o7d0
2 Nov 23
Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update
4:03pm
8-K/A
fydcif06i5 1b
17 Oct 23
Departure of Directors or Certain Officers
4:34pm
8-K
qbz77ndv
16 Oct 23
Departure of Directors or Certain Officers
8:31am